Items Tagged ‘Alimentary Pharmacology & Therapeutics’
February 5, 2016
Are Fecal Transplants Effective in Children with IBD?
Clostridium difficile infection (CDI) is the leading cause of nosocomial diarrhea and is increasing in prevalence both in adult and paediatric populations. Moreover, those with inflammatory bowel disease (IBD) are at increased risk of CDI. Fecal microbiota transplantation (FMT) is an effective treatment for recurrent CDI, but little data is available regarding the effectiveness and associated microbiome […]
Tags: Alimentary Pharmacology & Therapeutics, Clostridium difficile infection (CDI), fecal microbiome, fecal transplant, IBD, Mark Bartlett
August 22, 2014
By Margaret Shepard, Communications Specialist 
John Kisiel, M.D., discusses a recently published article in Alimentary Pharmacology & Therapeutics about serrated epithelial changes in patients with Crohn’s disease and ulcerative colitis. Patients with inflammatory bowel disease are at an increased risk for colorectal cancer. The risk is increased by how long patients have had the disease, how old they are, […]
Tags: Alimentary Pharmacology & Therapeutics, Crohn's disease, John Kisiel, serrated epithelial change, ulcerative colitis
June 27, 2014
Exclusive Enteral Nutrition and Pediatric Crohn’s Disease
By Margaret Shepard, Communications Specialist
Jeanne Tung, M.D., a pediatric gastroenterologist at Mayo Clinic, discusses a recently published article in Alimentary Pharmacology & Therapeutics about exclusive enteral nutrition (EEN) in pediatric Crohn’s disease. The results show EEN was associated with remission for pediatric Crohn’s disease. What is EEN? For several weeks to months, a patient drinks formula such as […]
Tags: Alimentary Pharmacology & Therapeutics, Crohn's disease, EEN, exclusive enteral nutrition, Jeanne Tung, pediatric Crohn's disease
January 6, 2014
Pregnancy and Inflammatory Bowel Disease
By Brent Westra 
When Sunanda Kane, M.D., sees female patients with inflammatory bowel disease (IBD), she is frequently asked how these conditions may affect pregnancy or the ability to get pregnant. A recent study also investigated this issue and found that there was no decrease in fertility in women with IBD who have not undergone significant abdominal or pelvic […]
Tags: Alimentary Pharmacology & Therapeutics, fertility, pregnancy, Sunanda Kane
November 10, 2013
Crohn’s Disease Activity Index (CDAI) & Patients with Irritable Bowel Syndrome (IBS)
By Brent Westra
Note: This post was originally published on Mayo Clinic’s Advancing the Science blog on April 30, 2013 Edward Loftus Jr., M.D., a gastroenterologist at Mayo Clinic specializing in the care and evaluation of patients with IBD, discusses the implications of recent article published in Alimentary Pharmacology & Therapeutics that found a group of patients with […]
Tags: Alimentary Pharmacology & Therapeutics, CDAI, Edward Loftus, IBS